Issue of Equity

RNS Number : 4641S
Law Debenture Corp PLC
16 March 2021
 

The Law Debenture Corporation p.l.c.

8th Floor

100 Bishopsgate

London

EC2N 4AG

 

16 March 2021

 

Issue of Equity

 

On 16 March 2021 The Law Debenture Corporation p.l.c. (the "Corporation" ) issued 25,000   new ordinary shares of 5 pence each at a price of £7.225 per share; these shares rank pari passu with the existing ordinary shares in issue. The issue price equates to a premium to the net asset value per share at the time of the transaction.

 

As a result of this issue, the total number of ordinary shares in issue now stands at 120,272,842 and the total number of voting rights in the Corporation is 120,272,842. There are no shares held in treasury.

 

The above figure of 120,272,842 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Corporation under the FCA's Disclosure Guidance and Transparency Rules.

 

The decision to issue equity follows the recent acquisition of Konexo UK's company secretarial business from Eversheds Sutherland (International) LLP, which the Corporation seeks to refinance, subject to the authority approved by shareholders on 7 April 2020.

 

Ordinary shares may be issued in light of the continued premium to net asset value at which they are trading, together with continued demand from existing and new investors for the ordinary shares. Ordinary shares will only be issued at a premium to net asset value and will be accretive to existing shareholders.

 

 

Law Debenture Corporate Services Limited

Company Secretary

 

Contact:   Alison Skerritt-Black   020 7696 5233

 

 

The Law Debenture Corporation p.l.c. is registered in England, company registration number 30397. LEI number - 2138006E39QX7XV6PP21

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFLFIRVAIRLIL
UK 100

Latest directors dealings